Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study

Bibliographic Details
Title: Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study
Authors: Desai, Sanjal, Mo, Clifton, Gaglione, Erika M., Yuan, Constance M., Stetler-Stevenson, Maryalice, Tian, Xin, Maric, Irina, Wake, Laura, Farooqui, Mohammed Z., Drinkwater, Dennis C., Soto, Susan, Valdez, Janet, Hughes, Thomas E., Nierman, Pia, Lotter, Jennifer, Marti, Gerald E., Pleyer, Christopher, Sun, Clare, Superata, Jeanine, Nichols, Cydney, Herman, Sarah E. M., Lindorfer, Margaret A., Taylor, Ronald P., Wiestner, Adrian, Ahn, Inhye E.
Source: Leukemia & lymphoma. 62(8):1816-1827
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100156246849.0x000001&indx=1&recIds=ETOCvdc_100156246849.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:10428194
Published in:Leukemia & lymphoma
Language:English